Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes

Heart failure with preserved ejection fraction: controversies, challenges and future directions

(2018) Rosita Zakeri et al.   HEART

Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes

(2018) Thomas A. Zelniker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics

(2016) Peter Godsk Jørgensen et al.   Diabetes & Vascular Disease Research

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function

(2016) Peter G. Jørgensen et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions

(2014) J. B. Halter et al.   DIABETES

Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients

(2013) Mark Richards et al.   JACC-Heart Failure

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

(2012) L. J. M. Boonman-de Winter et al.   DIABETOLOGIA

Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea

(2010) Alan Maisel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY